Form 4 for ZYME Zymeworks Inc.
Accepted 2025-08-12 00:00:00 ET · period of report 2025-08-11 · accession 0000950170-25-107544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-12 | 2025-08-12 | ZYME | Ciongoli Gregory Austin | Dir | A - Grant | $12.02 | +415.0K | 488.5K | +565% | +$4.99M |
| D | 2025-08-12 | 2025-08-11 | ZYME | Ciongoli Gregory Austin | Dir | A - Grant | $0.00 | +62.0K | 62.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | A | A | 415,000 | $12.02 | 488,500 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-08-11 | A | A | 62,000 | $0.00 | 62,000 | D | $12.44 · — to 2035-08-10 | 62,000 Common Stock | (F2) Stock options vest in 36 equal monthly installments starting one month after grant date of August 11, 2025. |